Repligen Completes Expansion of Manufacturing Facility - - BioPharm International

ADVERTISEMENT

Repligen Completes Expansion of Manufacturing Facility



Repligen has completed a 9,000-ft2 expansion of its manufacturing facilities at its Waltham, Massachusetts’s headquarters. The production suite more than doubles capacity for Repligen’s OPUS line of prepacked chromatography columns, with cleanrooms built to ISO 7 specifications providing an appropriately controlled environment for GMP production.

The facility expansion also triples warehouse space and includes purification and fermentation laboratories for optimization of existing manufacturing processes, new product development, and applications support. An additional 17,000 ft2 of space is reserved for future expansion of the same facility.

Source: Repligen

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines

Click here